Browse by Tags

• Accidents and Safety
• Acquired Immune Deficiency Syndrome
• Advertising and Marketing
• Aged
• Alzheimer's Disease
• Amgen Inc|AMGN|NASDAQ
• Anemia
• Anesthesia and Anesthetics
• Antibiotics
• Antidepressants
• Antitrust Actions and Laws
• Arthritis and Rheumatism
• Avastin (Drug)
• Baxter International Inc|BAX|NYSE
• Bayer AG|BAY|NYSE
• Biogen Idec Incorporated|BIIB|NASDAQ
• Biotechnology
• Birth Control and Family Planning
• Blood Clots
• Breast
• Bristol-Myers Squibb Co|BMY|NYSE
• Bush, George W
• Byetta (Drug)
• Cancer
• Celebrex (Drug)
• Children and Youth
• China
• Cholesterol
• Company Reports
• Conflicts of Interest
• CVS Corporation|CVS|NYSE
• Decisions and Verdicts
• Diabetes
• Diet and Nutrition
• Doctors
• Drugstores
• European Union
• Express Scripts Incorporated|ESRX|NASDAQ
• Food and Drug Administration
• Food Contamination and Poisoning
• Genentech Inc|DNA|NYSE
• Generic and Brand Name Products
• Genetics and Heredity
• GlaxoSmithKline PLC|GSK|NYSE
• GlaxoSmithKline|GSK|NYSE
• Health Insurance and Managed Care
• Heart
• Heparin (Drug)
• Hospitals
• House of Representatives
• ImClone Systems Incorporated|IMCL|NASDAQ
• India
• Insurance
• International Trade and World Market
• Inventions and Patents
• Johnson & Johnson Inc
• Labeling and Labels
• Lilly, Eli, & Co
• Malaria
• Medicare
• Medicine and Health
• Mental Health and Disorders
• Merck & Company Inc
• Mergers, Acquisitions and Divestitures
• Methadone
• Multiple Sclerosis
• Muscles
• Muscular Dystrophy
• Myriad Genetics Incorporated|MYGN|NASDAQ
• New England Journal of Medicine
• Novartis A.G|NVS|NYSE
• Osteoporosis
• Pfizer Inc|PFE|NYSE
• Prices (Fares, Fees and Rates)
• Ranbaxy Laboratories
• Recalls and Bans of Products
• Research
• Resveratrol (Chemical)
• Retail Stores and Trade
• Roche Holding Ltd|RHHBY|other-OTC
• Sales
• Schering Plough Corp|SGP|NYSE
• Schizophrenia
• Senate
• Statins (Cholesterol-Lowering Drugs)
• Stocks and Bonds
• Suits and Litigation
• Supreme Court
• Tests and Testing
• Tysabri (Drug)
• United States
• United States Economy
• United States Politics and Government
• Vermont
• Vytorin (Drug)
• Wall Street (NYC)
• Wines
• Wyeth|WYE|NYSE
• Zetia (Drug)
• Zyprexa (Drug)

• The Evidence Gap: British Balance Gain Against the Cost of the Latest Drugs

  Skyrocketing health care prices have led a growing number of countries to follow Britain’s example by asking how much life is worth. Posted Dec 03 2008, 04:13 AM by NYT > Home Page Filed under: Drugs (Pharmaceuticals), Medicine and Health, England

• Evidence Gap: British Balance Gain Versus Cost of Latest Drugs

  Skyrocketing health care prices have led a growing number of countries to follow Britain’s example when asking the hardest of questions: How much is life worth? Posted Dec 02 2008, 11:31 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, England

• Cleveland Clinic Discloses Doctors’ Industry Ties

  In the first such step by a major medical center, the clinic says it has begun publicly disclosing the business relationships its staff has with drug makers. Posted Dec 02 2008, 07:04 PM by NYT > Business Filed under: Drugs (Pharmaceuticals), Medicine and Health, Doctors, Conflicts of Interest, Cleveland Clinic

• Q & A: Time Capsules

  How do drugs taken once a week, once a month or even once a year do their work? Posted Dec 01 2008, 10:17 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health

• Europe Accuses Drug Makers of Padding Health Care Costs

  The European Union accused drug companies of adding billions of dollars to health care costs by delaying or blocking the sale of less-expensive generic medicines. Posted Nov 28 2008, 02:28 PM by NYT > Business Filed under: Drugs (Pharmaceuticals), European Union, Generic and Brand Name Products, Antitrust Actions and Laws

• The Evidence Gap: The Minimal Impact of a Big Hypertension Study

  Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs. Posted Nov 27 2008, 09:25 PM by NYT > Health Filed under: Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), Medicine and Health, Hypertension, Pfizer Inc|PFE|NYSE

• European Regulators Widen Inquiry Into Drug Makers

  Regulators in Europe led a second round of raids on drug companies, just days before their planned release of findings from an earlier antitrust investigation. Posted Nov 26 2008, 10:45 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), European Union, Antitrust Actions and Laws

• Research Center Tied to Drug Company

  Documents reveal that a renowned child psychiatrist pushed Johnson & Johnson to finance a research center whose goal was “to move forward the commercial goals of J&J.” Posted Nov 25 2008, 03:03 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, Children and Youth, Mental Health and Disorders, Johnson & Johnson Inc, Massachusetts General Hospital, Conflicts of Interest, Biederman, Joseph

• The Evidence Gap: New Arena for Testing of Drugs: Real World

  There is a growing movement to gather evidence to explore what treatment is best for typical patients with complex symptoms. Posted Nov 25 2008, 02:00 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, Research, Tests and Testing, Clinical Trials

• Diabetes Drug Linked to Higher Risk of Death

  Patients taking rosiglitazone, sold under the brand name Avandia, were more likely to suffer heart failure and to die than those taking a similar drug, according to a new study. Posted Nov 24 2008, 11:27 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, Diabetes, Avandia (Drug)

• Radio Host Has Drug Company Ties

  Dr. Frederick K. Goodwin, a psychiatrist, earned income from drug makers that he didn’t report on his show. Posted Nov 23 2008, 08:09 AM by NYT > Health Filed under: Drugs (Pharmaceuticals), Radio, Antidepressants, Conflicts of Interest, Goodwin, Frederick K.

• Conflicts of Interest May Ensnare Journalists, Too

  Researchers have documented what they say are “astonishing” financial ties between journalists and drug companies. Posted Nov 22 2008, 12:32 AM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, News and News Media, Conflicts of Interest

• Federal Court Upholds Drug Privacy Law

  The court upheld the right of states to prohibit the sale of doctor-specific prescription drug data that is widely used in pharmaceutical marketing. Posted Nov 18 2008, 10:21 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health, Doctors, Decisions and Verdicts

• National Briefing | New England: New Hampshire: Ruling on Prescriptions

  A federal appeals court upheld the constitutionality of the state’s first-in-the-nation law that restricts drug company access to some information about doctors’ prescription-writing habits. Posted Nov 18 2008, 09:40 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Medicine and Health

• National Briefing | Science and Health: Study Into Cancer Drug and Clot Risk

  The cancer drug Avastin raises the risk of blood clots in the veins by a third when added to chemotherapy, researchers said. Posted Nov 18 2008, 09:38 PM by NYT > Health Filed under: Drugs (Pharmaceuticals), Blood Clots, Avastin (Drug)